ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

ClinicalTrials.gov ID: NCT06605599

Public ClinicalTrials.gov record NCT06605599. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 2:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Fixed-dose Study to Evaluate the Efficacy, Safety, and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder

Study identification

NCT ID
NCT06605599
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
161 participants

Conditions and interventions

Interventions

  • ABBV-932 Drug
  • Placebo for ABBV-932 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 14, 2024
Primary completion
Nov 11, 2025
Completion
Dec 9, 2025
Last update posted
Jan 11, 2026

2024 – 2025

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Harmonex /ID# 267504 Dothan Alabama 36303
Advanced Research Center /ID# 267716 Anaheim California 92805
Axiom Research /ID# 267518 Colton California 92324
Collaborative Neuroscience Research - Garden Grove /ID# 267654 Garden Grove California 92845
Sun Valley Research Center /ID# 267708 Imperial California 92251
Alliance for Research Alliance for Wellness /ID# 267492 Long Beach California 90807
Excell Research /ID# 267541 Oceanside California 92056
Viking Clinical Research Center - Temecula /ID# 267634 Temecula California 92591
Accel Research Sites Network - St. Pete /ID# 267463 Largo Florida 33777
GMI Florida - Central Miami Medical Institute /ID# 267566 Miami Florida 33125
Allied Biomedical Res Inst Inc /ID# 267481 Miami Florida 33155
K2 Medical Research - Orlando - South Orlando Avenue /ID# 267567 Orlando Florida 32751
Segal Trials - West Broward Outpatient Research Site /ID# 267947 Tamarac Florida 33319-4985
Benchmark Research /ID# 267626 Shreveport Louisiana 71101
CenExel /ID# 267675 Gaithersburg Maryland 20877-1407
Arch Clinical Trials /ID# 267507 St Louis Missouri 63125
Duplicate_Oasis Clinical Research, LLC /ID# 267969 Las Vegas Nevada 89121
Center For Emotional Fitness - Cherry Hill /ID# 267661 Cherry Hill New Jersey 08002
Bio Behavioral Health /ID# 267493 Toms River New Jersey 08755
Neurobehavioral Research /ID# 267564 Cedarhurst New York 11516
New Hope Clinical Research - Inpatient unit /ID# 267465 Charlotte North Carolina 28211
Quest Therapeutics of Avon Lake /ID# 267558 Avon Lake Ohio 44012
OSU Psychiatry Department /ID# 267730 Columbus Ohio 43210
Sooner Clinical Research /ID# 267639 Oklahoma City Oklahoma 73116
Lehigh Center for Clinical Research /ID# 267451 Allentown Pennsylvania 18103
Suburban Research Associates - Media /ID# 267621 Media Pennsylvania 19063
Coastal Carolina Research Center, LLC /ID# 267550 Charleston South Carolina 29492
FutureSearch Trials of Dallas /ID# 267715 Dallas Texas 75231
Perceptive Pharma Research /ID# 267563 Richmond Texas 77407
Grayline Research Center /ID# 267466 Wichita Falls Texas 76309
Northwest Clinical Research Center /ID# 267505 Bellevue Washington 98007
Core Clinical Research /ID# 268534 Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06605599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06605599 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →